ArriVent BioPharma
AVBP
AVBP
54 hedge funds and large institutions have $404M invested in ArriVent BioPharma in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3.71% less ownership
Funds ownership: 68.37% → 64.66% (-3.7%)
Holders
54
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$10.3M | |
| 2 | +$7.84M | |
| 3 | +$2.76M | |
| 4 |
HLAM
Hidden Lake Asset Management
New York
|
+$689K |
| 5 |
State Street
Boston,
Massachusetts
|
+$582K |
Top Sellers
| 1 | -$5.12M | |
| 2 | -$3.7M | |
| 3 | -$2.71M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$2.61M |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
-$536K |